73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study sheds light on the mysterious evolution of DNA rings in tumors

Study sheds light on the mysterious evolution of DNA rings in tumors

by Charité - Universitätsmedizin BerlinNuclei and chromosomes of neuroblastoma cells. DNA rings are colored yellow, turquoise, or magenta. Each color is associated with different cancer genes. ©

Study sheds light on the mysterious evolution of DNA rings in tumors

by Charité - Universitätsmedizin BerlinNuclei and chromosomes of neuroblastoma cells. DNA rings are colored yellow, turquoise, or magenta. Each color is associated with different cancer genes. ©
Proton radiotherapy treats esophageal cancer for first time in Switzerland

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre
Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

byUTSouthwestern Medical CenterThis illustration depicts a nanoparticle (purple) activating the stimulator of interferon genes (STING) proteins (yellow) in dendritic cells to recruit cytot

Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

byUTSouthwestern Medical CenterThis illustration depicts a nanoparticle (purple) activating the stimulator of interferon genes (STING) proteins (yellow) in dendritic cells to recruit cytot
Study: Risk of cancer doubles for people with 'skewed' blood cells

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)
Palliative low-dose radiotherapy improves pain in hepatic cancer

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to
Access to cancer care can be just as important as care itself, new paper says

Access to cancer care can be just as important as care itself, new paper says

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainThe first step in addressing cancer is getting to your doctors' appointments. But that's not so easy

Access to cancer care can be just as important as care itself, new paper says

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainThe first step in addressing cancer is getting to your doctors' appointments. But that's not so easy
Study brings new understanding of multiple myeloma evolution

Study brings new understanding of multiple myeloma evolution

by University of Texas M. D. Anderson Cancer CenterGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.007A new study by researchers at The University of Texas

Study brings new understanding of multiple myeloma evolution

by University of Texas M. D. Anderson Cancer CenterGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.007A new study by researchers at The University of Texas
Investigators find disparities in mesothelioma survival due to social determinants, limited access

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af
Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

by Atrium Health Wake Forest BaptistCredit: Unsplash/CC0 Public DomainCancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. As metas

Disease progression, adverse radiation effects found to be low in patients undergoing preoperative SRS

by Atrium Health Wake Forest BaptistCredit: Unsplash/CC0 Public DomainCancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. As metas
A smart watch for lymphoedema management

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat
New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l